EUVIMEDEUVIMED entdecken
Crossref

Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011–2020

Yolanda Gondwe iD, April Evans iD, Apatsa Matatiyo, Gugulethu N Mapurisa, Coxcilly Kampani, Fred Chimzimu, Rob Krysiak, Nader Kim El-Mallawany iD, Julie M Gastier-Foster, John Hicks, David Berger, Nmazuo W Ozuah und 13 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Yolanda Gondwe und 24 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina Project-Malawi, Lilongwe, Malawi. Hauptthemen laut MEDLINE: Neoplasms, Laboratories, Hospital. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2011, a partnership between Kamuzu Central Hospital (KCH) and the University of North Carolina (UNC) led to the opening of the first diagnostic pathology laboratory in Lilongwe, Malawi's capital. Procedure A retrospective case series of malignancies diagnosed at the KCH–UNC pathology laboratory between 2011 and 2020 in pediatric and adolescent patients aged 0–18 years.

Results

Between 2011 and 2020, 12761 specimens were received from 5137 pediatric and adolescent patients. A malignant diagnosis was confirmed in 1498 (29%) of patients, with a median age of 10 years (interquartile range (IQR) 5–14) and 810 (54%) males. The most common malignancy was lymphoma (38%, 571/1498), including both non‐Hodgkin lymphomas (NHLs) (86%, 387/571), with Burkitt lymphoma accounting for 80% (309/387) of NHLs, and Hodgkin lymphoma (HL) (22%, 125/571). Next were sarcomas (22%, 325/1498), including Kaposi sarcoma (KS) (34%, 111/325), rhabdomyosarcoma (21%, 68/325), and osteosarcoma (19%, 61/325). Then carcinomas (9%, 139/1498), with the majority (53%, 73/139) being squamous cell carcinoma. Next were acute leukemias (6%, 95/1498), including acute lymphoblastic leukemia (66%, 63/95) and acute myeloid leukemia (32%, 30/95). These were followed by Wilms tumor (WT) (6%, 90/1498), retinoblastoma (4%,66/1498), neuroblastoma (2%, 32/1498), hepatic tumors (2%, 31/1498), and germ cell tumors (1%, 22/1498).

Conclusions

The most common pediatric tumors diagnosed in the KCH–UNC pathology laboratory were NHL, HL, KS, and WT. Given the challenges of under‐diagnosis, obtaining tissue biopsies, and reliance on clinical diagnosis, we suspect there is an underrepresentation of many pediatric cancers, including acute leukemias, brain tumors, and WT. Pathology diagnostic services and techniques need to be expanded further to aid the categorization of carcinomas and sarcomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLaboratories, HospitalHumansChildMaleAdolescentChild, PreschoolFemaleRetrospective StudiesMalawiInfantInfant, NewbornFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Burkitt lymphomapathologypediatric cancerpediatric malignanciessub‐Saharan Africa

Autor:innen und Institutionen

  • University of North Carolina Project-Malawi, Lilongwe, Malawi.
  • Department of Pediatric Hematology Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Stanford Health Roger Maris Cancer Center, Fargo, North Dakota, USA.
  • Texas Children's Cancer and Hematology Centers Global HOPE Program, Lilongwe, Malawi.
  • Department of Pediatrics, Section of Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Pathology and Immunology, Texas Childrens Hospital and Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Yolanda Gondwe, April Evans, Nader Kim El-Mallawany, Rizine Mzikamanda, Minke W H Huibers

Zitieren

APA

Gondwe, Y., Evans, A., Matatiyo, A., Mapurisa, G. N., Kampani, C., Chimzimu, F., Krysiak, R., El-Mallawany, N. K., Gastier-Foster, J. M., Hicks, J., Berger, D., Ozuah, N. W., McAtee, C. L., Mzikamanda, R., Huibers, M. W. H., Mpasa, A., Wachepa, S., Martin, S., Wasswa, P., …, & Westmoreland, K. D. (2025). Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011–2020. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31669

Vancouver

Gondwe Y, Evans A, Matatiyo A, Mapurisa GN, Kampani C, Chimzimu F, et al. Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011–2020. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31669

BibTeX
@article{Gondwe2025,
  author = {Gondwe, Yolanda and Evans, April and Matatiyo, Apatsa and Mapurisa, Gugulethu N and Kampani, Coxcilly and Chimzimu, Fred and Krysiak, Rob and El-Mallawany, Nader Kim and Gastier-Foster, Julie M and Hicks, John and Berger, David and Ozuah, Nmazuo W and McAtee, Casey L and Mzikamanda, Rizine and Huibers, Minke W H and Mpasa, Atupele and Wachepa, Stella and Martin, Steve and Wasswa, Peter and Mulenga, Maurice and Khan, Shiraz and Gopal, Satish and Tomoka, Tamiwe and Fedoriw, Yuri and Westmoreland, Katherine D},
  title = {Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011–2020},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31669}
}
Kostenlos starten →